IL83822A0 - Compositions for treating atherosclerosis comprising biologically active amino acids - Google Patents

Compositions for treating atherosclerosis comprising biologically active amino acids

Info

Publication number
IL83822A0
IL83822A0 IL83822A IL8382287A IL83822A0 IL 83822 A0 IL83822 A0 IL 83822A0 IL 83822 A IL83822 A IL 83822A IL 8382287 A IL8382287 A IL 8382287A IL 83822 A0 IL83822 A0 IL 83822A0
Authority
IL
Israel
Prior art keywords
compositions
amino acids
biologically active
active amino
treating atherosclerosis
Prior art date
Application number
IL83822A
Original Assignee
Dudrick Medical Research Fund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dudrick Medical Research Fund filed Critical Dudrick Medical Research Fund
Publication of IL83822A0 publication Critical patent/IL83822A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Exposure Of Semiconductors, Excluding Electron Or Ion Beam Exposure (AREA)
IL83822A 1986-09-10 1987-09-08 Compositions for treating atherosclerosis comprising biologically active amino acids IL83822A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90593486A 1986-09-10 1986-09-10

Publications (1)

Publication Number Publication Date
IL83822A0 true IL83822A0 (en) 1988-02-29

Family

ID=25421711

Family Applications (1)

Application Number Title Priority Date Filing Date
IL83822A IL83822A0 (en) 1986-09-10 1987-09-08 Compositions for treating atherosclerosis comprising biologically active amino acids

Country Status (8)

Country Link
KR (1) KR880701558A (en)
CN (1) CN87106235A (en)
AU (1) AU8033487A (en)
CA (1) CA1290692C (en)
DK (1) DK253688A (en)
IL (1) IL83822A0 (en)
WO (1) WO1988001872A1 (en)
ZA (1) ZA876782B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU620567B2 (en) * 1987-10-06 1992-02-20 Sharpe Research Pty. Limited Prevention of soft tissue damage
DE3916903A1 (en) * 1989-05-24 1991-02-28 Leopold Pharma Gmbh WAESSER COMPOSITION FOR PARENTERAL NUTRITION
AT394135B (en) * 1989-06-22 1992-02-10 Leopold Pharma Gmbh Aqueous amino acid solution for parenteral alimentation
AU655780B2 (en) * 1990-10-30 1995-01-12 Clintec Nutrition Company A method and composition for the protection of a metabolic recovery of ischemic cardiac tissue
US5852058A (en) * 1993-06-11 1998-12-22 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
US5891459A (en) 1993-06-11 1999-04-06 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
US5702065A (en) * 1994-01-21 1997-12-30 Gigatek Memory Systems Tape cartridge with reduced tangential drive force
TW200626080A (en) * 2000-10-13 2006-08-01 Chugai Pharmaceutical Co Ltd Food compositions comprising valine for improving lipid metabolism
US20040265358A1 (en) * 2001-12-21 2004-12-30 Petra Verhoef Modified methionine rich food products and process for their manufacture
CN103768601A (en) * 2012-10-22 2014-05-07 中国科学院上海生命科学研究院 Method for preventing and treating atherosclerosis through inhibition of micro-RNA155
CN110389231B (en) * 2018-04-19 2022-09-06 北京市心肺血管疾病研究所 Application of branched chain amino acid detection substance in preparation of post-operation prognosis risk assessment kit for aortic dissection patient

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2965542A (en) * 1958-02-12 1960-12-20 Castaigne Albert Pharmaceutical product for reducing the proportion of cholesterol in the blood
US3574857A (en) * 1968-04-01 1971-04-13 Smith Kline French Lab Antilipidemic methods using glutamic acid,threonine and proline
DE3228127A1 (en) * 1982-07-28 1984-02-02 Basf Ag, 6700 Ludwigshafen Amino acid solutions for infusion

Also Published As

Publication number Publication date
DK253688D0 (en) 1988-05-09
ZA876782B (en) 1988-09-28
DK253688A (en) 1988-05-09
CA1290692C (en) 1991-10-15
WO1988001872A1 (en) 1988-03-24
KR880701558A (en) 1988-11-03
CN87106235A (en) 1988-05-18
AU8033487A (en) 1988-04-07

Similar Documents

Publication Publication Date Title
FI102969B1 (en) Heat and pH stable subtilisin analogues and process for their preparation
HUT38892A (en) Process for preparing alpha-, omega-dicarboxylic acids and pharmaceutical compositions comprising the same as active substance
GB8907148D0 (en) Biologically active proteins
GB8700398D0 (en) Compositions for surface treatment
EP0139481A3 (en) Formulations comprising n-acyl-basic amino acids
AU7004487A (en) Process for spray drying amino acid composition
IL83822A0 (en) Compositions for treating atherosclerosis comprising biologically active amino acids
ZA874836B (en) Hydroxyphosphonocarboxylic acids
GB2174422B (en) Amino compositions for textile treatment
GB8710724D0 (en) Phenyldithiaalkanedioic acids
IL86777A0 (en) Plant treatment composition
GB8430255D0 (en) Biologically active oligopeptides
GB8622417D0 (en) Amino acid etc compositions
EP0253245A3 (en) Biologically active peptides tan-866
GB8325856D0 (en) Biologically active aromatic acids
IL82630A0 (en) Crystalline amino-protected amino acids and their preparation
GB8412183D0 (en) Biologically active nitrogen containing acids
IE891007L (en) Biologically active proteins
GB8531332D0 (en) Biologically active heterocyclic acids
ZA879256B (en) Biologically active agent
IL89437A0 (en) Method for treating skin conditions utilizing novel pharmaceutical compositions
GB8630041D0 (en) Biologically active compound
IE863343L (en) Composition for healing bone damage
CS504186A1 (en) Zpusob pripravy 5 amino 2 acylaminofenolu
CS731886A1 (en) Zpusob pripravy 2 amino 5 nitrothiobenzamidu